O
OCCUITY
We have recruited the best and brightest minds in fields ranging from optical engineering to industrial design, medical commerce to finance.|Occuity specialises in the design and production of handheld optical healthcare monitoring and screening devices for clinical and personal use.|Occuity specialises in the research, design and production of handheld non-contact optical instruments for use in healthcare screening and monitoring.|Search for your local Occuity distributor below. Become a Distributor? - click here · Occuity's products are distributed through a global network of experienced ...|Occuity is open to discussing investment from a range of investors. If you are able to self-certify as either an investment professional, HNWI or sophisticated ...|Occuity work with a number of approved recruitment partners to fulfil roles and provide full details below solely to welcome and encourage direct contact from ...|The Occuity AX1 will be the world's first handheld, optical, non-contact meter, capable of directly measuring axial length quickly, easily and safely.|We're pioneering technological solutions to alleviate some of Humanity's greatest healthcare challenges.
Country/Area ：United Kingdom
Company Email ：admin@occuity.com
Industry ：Medical Devices & EquipmentSafety and SecurityElectronicsMedical DevicesManufacturingRenewable Energy
Company address ：27 The Junipers Wokingham | RG41 4UX
Company website ：*****
Company phone ：+44 1183500800
Established ：2019
Company Revenue ：$8,774,000
Number of employees ：20 - 49
SIC Code ：38382
NAICS Code ：33333
Main Products ：Occuity Indigo - Glucose MonitorAX1 - Axial Length BiometerDiabetes MonitoringOphthalmic ProductsInvest NowPM1 - PachymeterDisease ScreeningAlzheimer's DiseaseGrants & ResearchVision and ValuesDistributor Marketing Hub
Company News
Occuity lands £343k grant to develop optical diabetes screening device
Nov 26, 2022
British MedTech Occuity eyes non-invasive screening of diabetes in non-clinical settings using handheld device.
Nov 26, 2022
Reading medical firm Occuity launch crowdfunding opportunity - The Business MagazineOct 26, 2022
Occuity, a quickly expanding MedTech business based out of Reading, is starting a new round of crowdfunding investment in order to raise the funds it needs to market its highly innovative...
Oct 26, 2022Occuity Indigo: Pain-free, optical, non-contact glucose meter in development that looks like ...May 28, 2022
The Occuity Indigo portable, non-contact glucose monitor is currently in the research and development phase. The device will utilize blue-light illumination to read biomarkers in the human eye to give the user an accurate blood sugar measurement. The Occuity Indigo looks like the neuralyzer from Men in Black with a concept design delivered by a former Apple designer.
May 28, 2022Web Summary
Q1: What is the address of Occuity's headquarters?
A1: The address of Occuity's headquarters is Floor 5, The Blade Abbey Sq, Reading, Berkshire, RG1 3BE.
Q2: What products does Occuity develop and market?
A2: Occuity develops and markets a range of handheld, non-contact optical devices for disease screening, monitoring, and ophthalmic applications, including pachymeters, axial length meters, pupillometers, keratometers, and glucose monitors.
Q3: In which industry is Occuity primarily operating?
A3: Occuity is primarily operating in the field of optical healthcare monitoring and screening, with a focus on developing innovative non-contact diagnostic devices for chronic diseases such as diabetes and Alzheimer's.
Q4: What services does Occuity offer to its customers?
A4: Occuity offers a range of services, including product distribution, marketing support, and technical assistance, as well as access to its expertise in ophthalmic diagnostics and disease screening.
Q5: How can one contact Occuity for general inquiries or investment opportunities?
A5: One can contact Occuity using the form provided on their website or by emailing them at info@occuity.com. For investors interested in joining Occuity's latest funding round, they can register their interest through the investor page.
Q6: What is the significance of Occuity's patented technology in its products?
A6: Occuity's patented technology enables non-contact diagnostics through the eye, which removes the risks associated with traditional diagnostic methods and makes it possible to screen for chronic diseases such as diabetes and Alzheimer's in non-clinical settings.
Q7: How does Occuity's product range benefit patients and clinicians?
A7: Occuity's products offer several advantages over existing techniques, including non-contact diagnostics, handheld and portable design, no-disposable requirements, and cost-effectiveness. These benefits make Occuity's devices safer, easier to use, and more environmentally friendly.
Q8: What is the company's vision for its product range?
A8: Occuity's vision is to deliver the world's first non-invasive, non-contacting monitoring device for chronic diseases such as diabetes and Alzheimer's disease.
A1: The address of Occuity's headquarters is Floor 5, The Blade Abbey Sq, Reading, Berkshire, RG1 3BE.
Q2: What products does Occuity develop and market?
A2: Occuity develops and markets a range of handheld, non-contact optical devices for disease screening, monitoring, and ophthalmic applications, including pachymeters, axial length meters, pupillometers, keratometers, and glucose monitors.
Q3: In which industry is Occuity primarily operating?
A3: Occuity is primarily operating in the field of optical healthcare monitoring and screening, with a focus on developing innovative non-contact diagnostic devices for chronic diseases such as diabetes and Alzheimer's.
Q4: What services does Occuity offer to its customers?
A4: Occuity offers a range of services, including product distribution, marketing support, and technical assistance, as well as access to its expertise in ophthalmic diagnostics and disease screening.
Q5: How can one contact Occuity for general inquiries or investment opportunities?
A5: One can contact Occuity using the form provided on their website or by emailing them at info@occuity.com. For investors interested in joining Occuity's latest funding round, they can register their interest through the investor page.
Q6: What is the significance of Occuity's patented technology in its products?
A6: Occuity's patented technology enables non-contact diagnostics through the eye, which removes the risks associated with traditional diagnostic methods and makes it possible to screen for chronic diseases such as diabetes and Alzheimer's in non-clinical settings.
Q7: How does Occuity's product range benefit patients and clinicians?
A7: Occuity's products offer several advantages over existing techniques, including non-contact diagnostics, handheld and portable design, no-disposable requirements, and cost-effectiveness. These benefits make Occuity's devices safer, easier to use, and more environmentally friendly.
Q8: What is the company's vision for its product range?
A8: Occuity's vision is to deliver the world's first non-invasive, non-contacting monitoring device for chronic diseases such as diabetes and Alzheimer's disease.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
